Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Kalvista Pharmaceuticals Inc. (KALV)

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1.
Vivo Capital

Albert Cha And Frank Kung

1,359,149 $38,899 3.87%
2.
Ghost Tree Capital

Ken Greenberg And David Kim

400,000 $11,448 -6% 3.1%
3.
Samsara BioCapital

Srini Akkaraju And Michael Dybbs

118,500 $3,391 -21% 2.66%
4.
RA Capital Management

Peter Kolchinsky

1,441,070 $41,243 1.77%
5.
Deerfield Management

James E. Flynn

650,000 $18,603 0.71%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$17.00 58,824 Director 388,766 2018-09-10 Filing
$17.00 1,058,824 Director 1,359,149 2018-09-10 Filing
$8.61 565,065 Director 934,484 2017-10-12 Filing
$8.50 850,000 Large Shareholder, Director 1,441,070 2017-10-12 Filing
$8.50 850,000 Large Shareholder, Director 1,441,070 2017-10-12 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$26.79 1,000 Officer 82,969 2019-04-22 Filing
$25.92 6,355 Officer 83,969 2019-04-22 Filing
$25.92 300 Officer, Director 258,510 2019-04-15 Filing
$24.76 9,700 Officer, Director 258,810 2019-04-15 Filing
$25.80 2,000 Officer 32,500 2019-04-22 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 1,831,548 $52,419 30.74%
2. 970,630 $27,779 16.19%
3. 388,766 $11,126 10.21%
4. 573,482 $16,413 4.8%
5. 205,500 $5,881 2.79%
News See All